Cargando…
Role of LOXL2 in the epithelial-mesenchymal transition and colorectal cancer metastasis
Colorectal cancer (CRC) is one of the most dangerous types of malignant tumors, and cancer metastasis is a major factor in the failure of CRC therapy. Recently, LOXL2 (lysyl oxidase-like 2) has been shown to represent a regulator of epithelial-mesenchymal transition (EMT) in different cancer types....
Autores principales: | Park, Pil-Gu, Jo, Su Ji, Kim, Min Jung, Kim, Hyun Jeong, Lee, Ji Hae, Park, Cheol Keun, Kim, Hyunki, Lee, Kang Young, Kim, Hoguen, Park, Jeon Han, Dong, Seung Myung, Lee, Jae Myun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655201/ https://www.ncbi.nlm.nih.gov/pubmed/29113306 http://dx.doi.org/10.18632/oncotarget.18170 |
Ejemplares similares
-
Emerging role of LOXL2 in the promotion of pancreas cancer metastasis
por: Park, Joon Seong, et al.
Publicado: (2016) -
Cellular inhibitor of apoptosis protein 2 promotes the epithelial-mesenchymal transition in triple-negative breast cancer cells through activation of the AKT signaling pathway
por: Jo, Su Ji, et al.
Publicado: (2017) -
Specific protein 1(SP1) regulates the epithelial-mesenchymal transition via lysyl oxidase-like 2(LOXL2) in pancreatic ductal adenocarcinoma
por: Kim, Im-kyung, et al.
Publicado: (2019) -
Effects of metformin and phenformin on apoptosis and epithelial‐mesenchymal transition in chemoresistant rectal cancer
por: Park, Ji‐Hye, et al.
Publicado: (2019) -
LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition
por: Cuevas, Eva P., et al.
Publicado: (2014)